Literature DB >> 9877189

Flagellin gene variation between clinical and environmental isolates of Burkholderia pseudomallei contrasts with the invariance among clinical isolates.

C Winstanley1, B A Hales, J E Corkill, M J Gallagher, C A Hart.   

Abstract

The flagellin gene sequence from a clinical isolate of Burkholderia pseudomallei was used to design oligonucleotide primers for PCR/RFLP analysis of flagellin gene variation among clinical and environmental isolates of B. pseudomallei. Genes from four clinical and six environmental isolates were amplified and compared by RFLP. The clinical isolates were indistinguishable, but variation was detected among some of the environmental isolates. Sequence analysis of flagellin gene amplified products demonstrated high levels of conservation amongst the flagellin genes of clinical isolates (>99% similarity), compared to the variation observed between the clinical isolates and one of the environmental isolates (<90% similarity). Genomic comparisons with pulsed-field gel electrophoresis (PFGE) revealed differences between the relationships inferred by flagellin genotyping and PFGE, suggesting that a combination of molecular methods may be useful for the subtyping of B. pseudomallei strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877189     DOI: 10.1099/00222615-47-8-689

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara(-) phenotypes.

Authors:  C Winstanley; C A Hart
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Sequence polymorphism and PCR-restriction fragment length polymorphism analysis of the flagellin gene of Burkholderia pseudomallei.

Authors:  Sun Tee Tay; Pui Ching Cheah; Savithiri D Puthucheary
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

3.  Short report: Predictors of severe disease in melioidosis patients in Kuala Lumpur, Malaysia.

Authors:  Ardita Dewi Roslani Mohd Roslani; Sun Tee Tay; Savithri D Puthucheary; Devi V Rukumani; I-Ching Sam
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

4.  A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.

Authors:  T Atkins; R G Prior; K Mack; P Russell; M Nelson; P C F Oyston; G Dougan; R W Titball
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

5.  Characterization of the mrgRS locus of the opportunistic pathogen Burkholderia pseudomallei: temperature regulates the expression of a two-component signal transduction system.

Authors:  Magdy E Mahfouz; T Hilton Grayson; David A B Dance; Martyn L Gilpin
Journal:  BMC Microbiol       Date:  2006-08-07       Impact factor: 3.605

6.  Utilization of Whole-Cell MALDI-TOF Mass Spectrometry to Differentiate Burkholderia pseudomallei Wild-Type and Constructed Mutants.

Authors:  Suthamat Niyompanich; Kitima Srisanga; Janthima Jaresitthikunchai; Sittiruk Roytrakul; Sumalee Tungpradabkul
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

7.  Source-identifying biomarker ions between environmental and clinical Burkholderia pseudomallei using whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).

Authors:  Suthamat Niyompanich; Janthima Jaresitthikunchai; Kitima Srisanga; Sittiruk Roytrakul; Sumalee Tungpradabkul
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.